会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明授权
    • Error correction trellis coding with periodically inserted known symbols
    • 误差校正网格编码,周期性插入已知符号
    • US07225392B2
    • 2007-05-29
    • US10090371
    • 2002-03-04
    • Dawei HuangFeng Qi
    • Dawei HuangFeng Qi
    • H03M13/03
    • H03M13/23
    • The present invention discloses a system and method for channel coding data within a digital communication system. A data receiving circuit receives a digital input data sequence and periodically inserts known symbols, such as zeros, into the digital input data sequence as part of a convolutional zero code of the present invention. It forms an expanded digital input data sequence. An encoder is operatively connected to the data receiving circuit and trellis encodes the expanded sequence to produce a channel coded data stream such that the number of connections between trellis nodes in a trellis are reduced.
    • 本发明公开了一种在数字通信系统内对数据进行信道编码的系统和方法。 数据接收电路接收数字输入数据序列,并且将已知的诸如零的符号周期地插入到数字输入数据序列中作为本发明的卷积零代码的一部分。 它形成一个扩展的数字输入数据序列。 编码器可操作地连接到数据接收电路,并对扩展的序列进行网格编码以产生信道编码的数据流,使得网格中网格节点之间的连接数量减少。
    • 4. 发明授权
    • Aglycon dammarane sapogenins, their use as anti-cancer agents, and a process for producing same
    • Aglycon dammarane sapogenins,它们作为抗癌剂的用途及其制备方法
    • US06949523B2
    • 2005-09-27
    • US09910887
    • 2001-07-24
    • Dong HuangDong Feng Qi
    • Dong HuangDong Feng Qi
    • C07J17/00A61K31/715A61K31/58A61K35/78
    • C07J17/005
    • This invention relates to a group of novel sapogenins, their use in anti-cancer applications, and to a process for their production. More particularly, this invention pertains to a novel group of dammarane sapogenins, PAM-120, PBM-110 and PBM-100 (the dammarance sapogenine structure is specifically clean of any sugar moieties (glycons) at any position and hydroxyl at C-20) and PAN-20 and PAN-30 (the dammarance sapogenin structure has sugar moieties but is free of hydroxyl at C-20), obtained by chemical cleavage of dammarane saponins. The invention also includes a novel application of the said sapogenins for anti-cancer treatment by using them separately or together, and/or jointly with other drugs, as well as to the process of producing these novel sapogenins. Said novel dammarane sapogenins show surprising anti-cancer effect when applied, particularly against multi-drug resistant cancers.
    • 本发明涉及一组新的皂甙元,它们在抗癌应用中的用途,以及它们的制备方法。 更具体地说,本发明涉及一组新的一组抗坏血酸皂苷元PAM-120,PBM-110和PBM-100(在任何位置上任何糖部分(糖)和C-20处的羟基) 和PAN-20和PAN-30(该抑制皂苷元结构具有糖部分,但在C-20时不含羟基),通过化学裂解dammarane皂甙获得。 本发明还包括通过分别或一起使用它们,和/或与其它药物联合使用所述皂苷元进行抗癌治疗的新应用,以及生产这些新型皂甙元的方法。 所述新型的dammarane sapogenins在使用时显示出惊人的抗癌作用,特别是针对多重耐药性癌症。
    • 5. 发明授权
    • Dammarane sapogenins, their use as anti-cancer agents, and a process for producing same
    • 丹参皂苷元,它们作为抗癌剂的用途及其制备方法
    • US06888014B2
    • 2005-05-03
    • US09982018
    • 2001-10-19
    • Dong HuangDong Feng Qi
    • Dong HuangDong Feng Qi
    • A61K9/00A61K31/575A61K31/704A61K36/25A61P35/00C07J9/00C07J17/00A61K31/56C07J53/00
    • C07J17/005
    • This invention relates to a group of novel sapogenins, their use in anti-cancer applications, and to a process for their production. More particularly, this invention pertains to a novel group of dammarane sapogenins, PAM-120, PBM-110 and PBM-100 (the dammarance sapogenine structure is specifically clean of any sugar moieties (glycons) at any position and hydroxyl at C-20) and PAN-20 and PAN-30 (the dammarance sapogenin structure has sugar moieties but is free of hydroxyl at C-20), obtained by chemical cleavage of dammarane saponins. The invention also includes a novel application of the said sapogenins for anti-cancer treatment by using them separately or together, and/or jointly with other drugs, as well as to the process of producing these novel sapogenins. Said novel dammarane sapogenins show surprising anti-cancer effect when applied, particularly against multi-drug resistant cancers.
    • 本发明涉及一组新的皂甙元,它们在抗癌应用中的用途,以及它们的制备方法。 更具体地说,本发明涉及一组新的一组抗坏血酸皂苷元PAM-120,PBM-110和PBM-100(在任何位置上任何糖部分(糖)和C-20处的羟基) 和PAN-20和PAN-30(该抑制皂苷元结构具有糖部分,但在C-20时不含羟基),通过化学裂解dammarane皂甙获得。 本发明还包括通过分别或一起使用它们,和/或与其它药物联合使用所述皂苷元进行抗癌治疗的新应用,以及生产这些新型皂甙元的方法。 所述新型的dammarane sapogenins在使用时显示出惊人的抗癌作用,特别是针对多重耐药性癌症。
    • 7. 发明授权
    • Method and system for interference suppression in WCDMA systems
    • WCDMA系统干扰抑制方法与系统
    • US08284819B2
    • 2012-10-09
    • US12582771
    • 2009-10-21
    • Mark HahmWei LuoArkady Molev-ShteimanHongwei KongXiao-Feng QiLi Fung ChangNelson Sollenberger
    • Mark HahmWei LuoArkady Molev-ShteimanHongwei KongXiao-Feng QiLi Fung ChangNelson Sollenberger
    • H04B1/00
    • H04B1/712H04J11/0063H04J13/0044H04J13/0048
    • Aspects of a method and system for interference suppression in WCDMA systems may include one or more circuits that are operable to receive a plurality of multipath signals via one or more receiving antennas. A plurality of weighting factor values may be computed based on the received multipath signals. Estimated signals may be based on the weighting factor values. Residual signals may be generated based on received signals and the estimated signals. Addback signals may be generated based on the estimated signals and the residual signals. Updated estimated signals may be generated based on the addback signals and the weighting factor values. Incremental signals may be generated based on the updated estimated signals and addback signals. Updated residual signals may be generated based on the incremental signals and previous residual signals. The interference suppressed signals may be generated based on the updated residual signals and updated estimated signals.
    • 用于WCDMA系统中的干扰抑制的方法和系统的方面可以包括可操作以经由一个或多个接收天线接收多个多径信号的一个或多个电路。 可以基于接收的多路径信号来计算多个加权因子值。 估计信号可以基于加权因子值。 可以基于接收的信号和估计的信号来产生残余信号。 可以基于估计的信号和残留信号来生成附加信号。 可以基于附加信号和加权因子值来生成更新的估计信号。 可以基于更新的估计信号和加法信号来产生增量信号。 可以基于增量信号和先前的剩余信号来生成更新的残留信号。 可以基于更新的残差信号和更新的估计信号来产生干扰抑制信号。
    • 10. 发明授权
    • System and method for restoring data from a remote repository
    • 从远程存储库恢复数据的系统和方法
    • US09268799B1
    • 2016-02-23
    • US13928843
    • 2013-06-27
    • Feng QiPei MaoGuohua Chen
    • Feng QiPei MaoGuohua Chen
    • G06F17/30
    • G06F11/1469G06F11/1451G06F2201/835
    • A method includes receiving a request to restore a memory of a client and determining a selected full session from a plurality of full sessions, each full session comprising a respective copy of data received from the memory of the client and a respective backup time stamp. The selected full session includes a most recent full backup having a respective backup time stamp prior to a selected restore time. The method further includes copying the selected full session to a restore session and determining a selected incremental session from a plurality of incremental sessions. Each incremental session includes a respective incremental backup time stamp, and respective changes to the data received from the memory of the client. The method further includes modifying the restore session in a cloud computing environment based on the selected incremental session, and transmitting the modified restore session across a network to the client.
    • 一种方法包括接收请求以恢复客户端的存储器并且从多个完整会话确定所选择的完整会话,每个完整会话包括从客户端的存储器接收的相应的数据副本和相应的备份时间戳。 所选的完整会话包括在选择的恢复时间之前具有各自的备份时间戳的最新的完整备份。 该方法还包括将所选择的完整会话复制到恢复会话并且从多个增量会话确定所选择的增量会话。 每个增量会话包括相应的增量备份时间戳,以及对从客户机的存储器接收到的数据的相应改变。 该方法还包括基于所选择的增量会话在云计算环境中修改恢复会话,以及通过网络将修改的恢复会话发送到客户端。